Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prantera

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2003
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trialP Paoluzi, G D'Albasio, A Pera, et al.
Gastroenterology|January 29, 1999
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study GroupG Hellers, A Cortot, D Jewell, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upA Kohn, M Daperno, A Armuzzi, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current managementS P L Travis, E F Stange, M Lémann, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2003
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trialP Paoluzi, G D'Albasio, A Pera, et al.
Gastroenterology|January 29, 1999
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study GroupG Hellers, A Cortot, D Jewell, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upA Kohn, M Daperno, A Armuzzi, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current managementS P L Travis, E F Stange, M Lémann, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
Pageof 7